Provisional programme : Pharmaceuticals in Global Health – Life, Security and Governance : ... : Centre for Global Health Policy : University of Sussex

19.00

Dinner for participants arriving on the day before the workshop

09.00	Coffee/ tea and registration
09.30	Welcome and participants introductions
10.00	Roundtable I: The Pharmaceuticalisation of Society and New Visions of Life To what extent is the focus on pharmaceuticals in global health linked to wider epistemic shifts in our understanding of biological life? How are pharmaceuticalisation processes shaping – and also shaped by – the field of global health? What are the new tensions that arise specifically around a molecular and pharmaceutical biopolitics?
11.00	Coffee/tea
11.30	Roundtable I: Discussion
12.30	Lunch
14.30	Roundtable II: Pharmaceuticals, Health and Security What role do the rise of global health security considerations play in intensifying the recourse to pharmaceutical solutions in global health policy? What happens in practice when the logics of pharmaceuticalisation and security collide, and what are the tensions between such pharmaceutical and security ‘logics’? Is the pharmaceutical turn in global health security indicative of wider shift in our understanding of security?
15.30	Coffee/tea
16.00	Roundtable II: Discussion
17.00	Finish Day 1
19.00	Dinner

09.00	Roundtable III: Global Governance for Health or Pharmaceuticals? How has the focus on pharmaceuticals shaped the character of global health governance? What tensions emerge between the global governance for health and the global governance for pharmaceuticals? Is the use of pharmaceuticals in global health policy indicative of a wider technological shift in global governance?
10.00	Roundtable III: Discussion
11.00	Coffee
11.30	Roundtable IV: The Political Economy of Global Health in the Era of Pharmaceuticalisation How has the growing political demand for pharmaceuticals as ‘public goods’ affected the political economy of global health? How has the role of pharmaceutical companies from emerging markets in global health changed in the last two decades? What are key developments in the pharmaceutical industry that will affect the political economy of global health in the future?
12.30	Roundtable IV: Discussion
13.30	Lunch
14.30	Concluding session: Where to go from here?
15.30	Close and thank you